Einarson, Thomas R <br/><br/>
Dose escalation of biologics in Crohn's disease: critical review of observational studies.  [electronic resource] 

 -  Current medical research and opinion  08 2017 
 - 1433-1449 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1080/03007995.2017.1335001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--administration & dosage<br/>Adult<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Biological Products--administration & dosage<br/>Crohn Disease--drug therapy<br/>Dose-Response Relationship, Drug<br/>Europe<br/>Humans<br/>Infliximab--administration & dosage<br/>Treatment Outcome